Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large-Cell, Anaplastic

Explore clinical trials studying Lymphoma, Large-Cell, Anaplastic. Study availability and eligibility vary by location and protocol.

289 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large-Cell, Anaplastic trial results

Not Yet Recruiting

BV-CHP Real-life and Biological Evidences in Patients With sALCL

NCT07467317

Conditions
Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • A.O.R.N. S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy
  • I.R.C.C.S. Centro di Riferimento Oncologico - S.O.C. Oncologia medica e dei tumori immuno-correlati Aviano, Italy
  • I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
  • A.S.S.T Papa Giovanni XXIII - S.C. Ematologia Bergamo, Italy
View all 19 locations
View Trial Details
Completed

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

NCT02232516

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +32 more
Locations
  • City of Hope Duarte, California, United States
  • Yale University New Haven, Connecticut, United States
  • Northwestern University Chicago, Illinois, United States
  • Weill Cornell Medicine New York, United States
View Trial Details
Completed

Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

NCT01909934

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • UZ Leuven Leuven, Belgium
View all 40 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00278408

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations
  • Rigshospitalet, Department of Hematology Copenhagen, Denmark
  • Amtssygehuset i Herlev Herlev, Denmark
  • GMP Tummes/Weinberg Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
View all 152 locations
View Trial Details
Completed

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00001337

Conditions
Anaplastic Large-Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +21 more
Locations
  • Holy Cross Hospital, Fort Lauderdale Fort Lauderdale, Florida, United States
  • University of Maryland, Baltimore Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions